JBS secures historic shareholder approval to list on New York Stock Exchange

JBS has received shareholder approval to list its shares on the New York Stock Exchange — a milestone the company has pursued for a decade. In a meeting that lasted just 10 minutes to announce the result, JBS gained the approval of a majority of minority shareholders to proceed with the dual listing. Voting percentages were not disclosed.

The decision was left entirely to minority shareholders, as the company’s two largest shareholders — J&F and BndesPar — were barred from voting.

Following approval, JBS shares are expected to begin trading on the NYSE on June 12, paving the way for a potential revaluation of the company. JBS, the world’s largest animal protein company, with revenues exceeding R$ 400 billion (around US$ 71 billion), has been trading at a significant discount compared to its U.S.-listed peers.